Protein kinase CK2 is a constitutively active enzyme that promotes cell survival: Strategies to identify CK2 substrates and manipulate its activity in mammalian cells

Methods in Enzymology

Volumn 484, Issue C, 2010, Pages 471-493

  Turowec, Jacob P ^a   Duncan, James S ^a   French, Ashley C ^a   Gyenis, Laszlo ^a   St Denis, Nicole A ^a   Vilk, Greg ^a   Litchfield, David W ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; COMPLEMENTARY DNA; EPITOPE; PHOSPHOTRANSFERASE INHIBITOR; RECOMBINANT ENZYME; TETRACYCLINE;

AUTOPHOSPHORYLATION; BOOK; CARCINOGENESIS; CELL SURVIVAL; DRUG SELECTIVITY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME ISOLATION; ENZYME PHOSPHORYLATION; ENZYME PURIFICATION; ENZYME SUBSTRATE; EUKARYOTIC CELL; HUMAN; IN VITRO STUDY; MAMMAL CELL; MOLECULAR THERAPY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSGENIC MOUSE;

EUKARYOTA; MAMMALIA; MUS MUSCULUS;

EID: 78049257310     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381298-8.00023-X     Document Type: Chapter

References (28)

1. Ahn N.G., Weiel J.E., Chan C.P., Krebs E.G. Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells. J. Biol. Chem. 1990, 265:11487-11494.
2. Boyle W.J., van der Geer P., Hunter T. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 1991, 201:100-149.
3. Canton D.A., Olsten M.E., Kim K., Doherty-Kirby A., Lajoie G., Cooper J.A., Litchfield D.W. The pleckstrin homology domain-containing protein CKIP-1 is involved in regulation of cell morphology and the actin cytoskeleton and interaction with actin capping protein. Mol. Cell. Biol. 2005, 25:3519-3534.
4. Di Maira G., Brustolon F., Bertacchini J., Tosoni K., Marmiroli S., Pinna L.A., Ruzzene M. Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level. Oncogene 2007, 26:6915-6926.
5. Duncan J.S., Litchfield D.W. Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim. Biophys. Acta 2008, 1784:33-47.
6. Duncan J.S., Gyenis L., Lenehan J., Bretner M., Graves L.M., Haystead T.A., Litchfield D.W. An unbiased evaluation of CK2 inhibitors by chemoproteomics: Characterization of inhibitor effects on CK2 and identification of novel inhibitor targets. Mol. Cell. Proteomics 2008, 7:1077-1088.
7. Duncan J.S., Turowec J.P., Vilk G., Li S.S., Gloor G.B., Litchfield D.W. Regulation of cell proliferation and survival: Convergence of protein kinases and caspases. Biochim. Biophys. Acta 2010, 1804:505-510.
8. Englert C., Hou X., Maheswaran S., Bennett P., Ngwu C., Re G.G., Garvin A.J., Rosner M.R., Haber D.A. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 1995, 14:4662-4675.
9. Faust R.A., Tawfic S., Davis A.T., Bubash L.A., Ahmed K. Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro. Head Neck 2000, 22:341-346.
10. Grankowski N., Boldyreff B., Issinger O.G. Isolation and characterization of recombinant human casein kinase II subunits alpha and beta from bacteria. Eur. J. Biochem. 1991, 198:25-30.
11. Hunter T. Signaling-2000 and Beyond. Cell 2000, 100:113-127.
12. Kuenzel E.A., Krebs E.G. A synthetic peptide substrate specific for casein kinase II. Proc. Natl. Acad. Sci. USA 1985, 82:737-741.
13. Kuenzel E.A., Mulligan J.A., Sommercorn J., Krebs E.G. Substrate specificity determinants for casein kinase II as deduced from studies with synthetic peptides. J. Biol. Chem. 1987, 262:9136-9140.
14. Landesman-Bollag E., Romieu-Mourez R., Song D.H., Sonenshein G.E., Cardiff R.D., Seldin D.C. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 2001, 20:3247-3257.
15. Litchfield D.W. Protein kinase CK2: Structure, regulation and role in cellular decisions of life and death. Biochem. J. 2003, 369:1-15.
16. Meggio F., Pinna L.A. One-thousand-and-one substrates of protein kinase CK2?. FASEB J. 2003, 17:349-368.
17. Meggio F., Boldyreff B., Marin O., Marchiori F., Perich J.W., Issinger O.G., Pinna L.A. The effect of polylysine on casein-kinase-2 activity is influenced by both the structure of the protein/peptide substrates and the subunit composition of the enzyme. Eur. J. Biochem. 1992, 205:939-945.
18. Messenger M.M., Saulnier R.B., Gilchrist A.D., Diamond P., Gorbsky G.J., Litchfield D.W. Interactions between protein kinase CK2 and Pin1. Evidence for phosphorylation-dependent interactions. J. Biol. Chem. 2002, 277:23054-23064.
19. Penner C.G., Wang Z., Litchfield D.W. Expression and localization of epitope-tagged protein kinase CK2. J. Cell. Biochem. 1997, 64:525-537.
20. Reed S.E., Staley E.M., Mayginnes J.P., Pintel D.J., Tullis G.E. Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors. J. Virol. Methods 2006, 138:85-98.
21. Salvi M., Sarno S., Cesaro L., Nakamura H., Pinna L.A. Extraordinary pleiotropy of protein kinase CK2 revealed by Weblogo phosphoproteome analysis. Biochim. Biophys. Acta 2009, 1793:847-859.
22. Sarno S., Salvi M., Battistutta R., Zanotti G., Pinna L.A. Features and potentials of ATP-site directed CK2 inhibitors. Biochim. Biophys. Acta 2005, 1754:263-270.
23. Seldin D.C., Leder P. Casein kinase II alpha transgene-induced murine lymphoma: Relation to theileriosis in cattle. Science 1995, 267:894-897.
24. St-Denis N.A., Litchfield D.W. Protein kinase CK2 in health and disease: From birth to death: The role of protein kinase CK2 in the regulation of cell proliferation and survival. Cell. Mol. Life Sci. 2009, 66:1817-1829.
25. Tegge W.J., Frank R. Analysis of protein kinase substrate specificity by the use of peptide libraries on cellulose paper (SPOT-method). Methods Mol. Biol. 1998, 87:99-106.
26. Vilk G., Saulnier R.B., St Pierre R., Litchfield D.W. Inducible expression of protein kinase CK2 in mammalian cells. Evidence for functional specialization of CK2 isoforms. J. Biol. Chem. 1999, 274:14406-14414.
27. Vilk G., Weber J.E., Turowec J.P., Duncan J.S., Wu C., Derksen D.R., Zien P., Sarno S., Donella-Deana A., Lajoie G., Pinna L.A., Li S.S., et al. Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells. Cell. Signal. 2008, 20:1942-1951.
28. Zien P., Duncan J.S., Skierski J., Bretner M., Litchfield D.W., Shugar D. Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: Evaluation of their effects on cells and different molecular forms of human CK2. Biochim. Biophys. Acta 2005, 1754:271-280.